Doak takes skin cancer prevention on the road

Bradley Pharmaceuticals' Doak Dermatologics division launched its Skin Cancer Screening Tour, a corporate campaign featuring a 38-foot “Mobile Diagnosis Vehicle” popping up at sun-drenched events throughout the summer.

Doak manufactures Solaraze for precancerous actinic keratosis, the most common precancerous skin condition. Together with PR firm Biosector 2, and partnering with the Skin Cancer Foundation, the bus debuted at San Francisco's Fisherman's Wharf in March and will end the tour in New York City in October.

The tour is soaking up local media coverage and vying for a place in the Guinness Book of World Records under “Most screenings in one day.” Scheduled stops include the LA Marathon and the Tampa Zoo, along with a host of malls and beaches, particularly targeting the more cancer-prone fair-skinned.

Examinations, performed by board-certified local volunteer dermatologists, last from two to five minutes. After exposed areas are inspected with a special magnifying glass, visitors are asked to fill out a risk-assessment form and can give contact information for follow-up materials. 

You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.